Intramyocardial Injection of Autologous UCB-MNC During Fontan Surgery for SRV Dependent CHD
Phase I Study of Intramyocardial Injection of Autologous Umbilical Cord Blood-Derived Mononuclear Cells During Fontan Surgical Palliation of Single Right Ventricle-Dependent Congenital Heart Disease
Sponsor: Children's Hospital Colorado
This PHASE1 trial investigates Congenital Heart Disease, SRV Dependent and is currently ongoing. Children's Hospital Colorado leads this study, which shows 7 recorded versions since 2021 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
7 versions recorded-
Jul 2025 — Present [monthly]
Active Not Recruiting PHASE1
-
Sep 2024 — Jul 2025 [monthly]
Active Not Recruiting PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE1
-
Mar 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
-
Feb 2023 — Mar 2024 [monthly]
Recruiting PHASE1
▶ Show 2 earlier versions
-
Jun 2022 — Feb 2023 [monthly]
Recruiting PHASE1
Status: Not Yet Recruiting → Recruiting
-
Jun 2021 — Jun 2022 [monthly]
Not Yet Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Children's Hospital Colorado
- Children's Hospital Los Angeles
- Children's Hospital Medical Center, Cincinnati
- Children's Hospital of Philadelphia
- Children's Hospitals and Clinics of Minnesota
- Children's of Alabama
- Mayo Clinic
- Ochsner Health System
- The Hospital for Sick Children
- Timothy J Nelson, MD, PhD
- University of Oklahoma
For direct contact, visit the study record on ClinicalTrials.gov .